Dr Miles Andrews
Dr Andrews is a Medical Oncologist and Head of Immuno-oncology at The Alfred, and Senior Research Fellow at Monash University.
Dr Andrews has clinical sub-specialty interests in the management of patients with cancers of the skin, chest, and head & neck. After gaining his specialist qualifications in Medical Oncology in 2012, he completed a PhD in genomics and melanoma biology at the Olivia Newton-John Cancer Research Institute and University of Melbourne, followed by a three-year postdoctoral fellowship at the University of Texas MD Anderson Cancer Center focused primarily on multi-platform biomarker studies of cancer immunotherapy and targeted therapy.
Dr Andrews is the clinical lead for melanoma registry projects through the Personalised Oncology Division at WEHI. He is actively involved with cancer clinical trials as a Principal or Co-Investigator at The Alfred and engages with the supervision/mentoring of trainees.
As a senior research fellow with Monash University, Dr Andrews leads several clinical and biospecimen-driven translational research projects evaluating the clinical outcomes, biomarkers, and fundamental biology of cancer therapies. He has particular expertise in cancer immunobiology, integrative immunogenomic analyses and the cancer microbiome, having published in these fields in journals such as Science, Nature Medicine, Cell, Lancet Oncology, and PNAS.
Professional associations and appointments
- Medical Oncology Group of Australia
- American Society of Clinical Oncology
- European Society of Medical Oncology
- Society for Immunotherapy of Cancer
- Deputy Chair, Medical Oncology Discipline Specific Advisory, Melanoma and Skin Cancer Trials Ltd.